Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP

Roman Tomazin, Ann Hill, Pieter Jugovic, Ian York, Peter Van Endert, Hidde L. Ploegh, David W. Andrews, David Johnson

Research output: Contribution to journalArticle

204 Citations (Scopus)

Abstract

The herpes simplex virus (HSV) ICP47 protein inhibits the MHC class I antigen presentation pathway by inhibiting the transporter associated with antigen presentation (TAP) which translocates peptides across the endoplasmic reticulum membrane. At present, ICP47 is the only inhibitor of TAP. Here, we show that ICP47 produced in bacteria can block human, but not mouse, TAP, and that heat denaturation of ICP47 has no effect on its ability to block TAP. ICP47 inhibited peptide binding to TAP without affecting ATP binding, consistent, with previous observations that the peptide binding and ATP binding sites of TAP are distinct. ICP47 bound to TAP with a higher affinity (KD ~5 x 10-8 M) than did peptides, and ICP47 did not dissociate from TAP. ICP47 was not transported by TAP and remained sensitive to proteases added from the cytosolic surface of the membrane. Peptides acted as competitive inhibitors of ICP47 binding to TAP, and this inhibition required a 100- to 1000-fold molar excess of peptide. These results demonstrate that ICP47 binds to a site which includes the peptide binding domain of TAP and remains bound to this site in a stable fashion.

Original languageEnglish (US)
Pages (from-to)3256-3266
Number of pages11
JournalEMBO Journal
Volume15
Issue number13
StatePublished - Jul 1 1996

Fingerprint

Binding Sites
Peptides
Antigen Presentation
Adenosine Triphosphate
Histocompatibility Antigens Class I
Membranes
Denaturation
Endoplasmic Reticulum
Peptide Hydrolases
Hot Temperature
Herpes simplex virus ICP47 protein
Bacteria
Antigens

Keywords

  • Herpes simplex virus
  • ICP47
  • Peptide binding site
  • TAP

ASJC Scopus subject areas

  • Genetics
  • Cell Biology

Cite this

Tomazin, R., Hill, A., Jugovic, P., York, I., Van Endert, P., Ploegh, H. L., ... Johnson, D. (1996). Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO Journal, 15(13), 3256-3266.

Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. / Tomazin, Roman; Hill, Ann; Jugovic, Pieter; York, Ian; Van Endert, Peter; Ploegh, Hidde L.; Andrews, David W.; Johnson, David.

In: EMBO Journal, Vol. 15, No. 13, 01.07.1996, p. 3256-3266.

Research output: Contribution to journalArticle

Tomazin, R, Hill, A, Jugovic, P, York, I, Van Endert, P, Ploegh, HL, Andrews, DW & Johnson, D 1996, 'Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP', EMBO Journal, vol. 15, no. 13, pp. 3256-3266.
Tomazin R, Hill A, Jugovic P, York I, Van Endert P, Ploegh HL et al. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO Journal. 1996 Jul 1;15(13):3256-3266.
Tomazin, Roman ; Hill, Ann ; Jugovic, Pieter ; York, Ian ; Van Endert, Peter ; Ploegh, Hidde L. ; Andrews, David W. ; Johnson, David. / Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. In: EMBO Journal. 1996 ; Vol. 15, No. 13. pp. 3256-3266.
@article{66a58970dfdc4c8bbf8ada564441dafc,
title = "Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP",
abstract = "The herpes simplex virus (HSV) ICP47 protein inhibits the MHC class I antigen presentation pathway by inhibiting the transporter associated with antigen presentation (TAP) which translocates peptides across the endoplasmic reticulum membrane. At present, ICP47 is the only inhibitor of TAP. Here, we show that ICP47 produced in bacteria can block human, but not mouse, TAP, and that heat denaturation of ICP47 has no effect on its ability to block TAP. ICP47 inhibited peptide binding to TAP without affecting ATP binding, consistent, with previous observations that the peptide binding and ATP binding sites of TAP are distinct. ICP47 bound to TAP with a higher affinity (KD ~5 x 10-8 M) than did peptides, and ICP47 did not dissociate from TAP. ICP47 was not transported by TAP and remained sensitive to proteases added from the cytosolic surface of the membrane. Peptides acted as competitive inhibitors of ICP47 binding to TAP, and this inhibition required a 100- to 1000-fold molar excess of peptide. These results demonstrate that ICP47 binds to a site which includes the peptide binding domain of TAP and remains bound to this site in a stable fashion.",
keywords = "Herpes simplex virus, ICP47, Peptide binding site, TAP",
author = "Roman Tomazin and Ann Hill and Pieter Jugovic and Ian York and {Van Endert}, Peter and Ploegh, {Hidde L.} and Andrews, {David W.} and David Johnson",
year = "1996",
month = "7",
day = "1",
language = "English (US)",
volume = "15",
pages = "3256--3266",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Nature Publishing Group",
number = "13",

}

TY - JOUR

T1 - Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP

AU - Tomazin, Roman

AU - Hill, Ann

AU - Jugovic, Pieter

AU - York, Ian

AU - Van Endert, Peter

AU - Ploegh, Hidde L.

AU - Andrews, David W.

AU - Johnson, David

PY - 1996/7/1

Y1 - 1996/7/1

N2 - The herpes simplex virus (HSV) ICP47 protein inhibits the MHC class I antigen presentation pathway by inhibiting the transporter associated with antigen presentation (TAP) which translocates peptides across the endoplasmic reticulum membrane. At present, ICP47 is the only inhibitor of TAP. Here, we show that ICP47 produced in bacteria can block human, but not mouse, TAP, and that heat denaturation of ICP47 has no effect on its ability to block TAP. ICP47 inhibited peptide binding to TAP without affecting ATP binding, consistent, with previous observations that the peptide binding and ATP binding sites of TAP are distinct. ICP47 bound to TAP with a higher affinity (KD ~5 x 10-8 M) than did peptides, and ICP47 did not dissociate from TAP. ICP47 was not transported by TAP and remained sensitive to proteases added from the cytosolic surface of the membrane. Peptides acted as competitive inhibitors of ICP47 binding to TAP, and this inhibition required a 100- to 1000-fold molar excess of peptide. These results demonstrate that ICP47 binds to a site which includes the peptide binding domain of TAP and remains bound to this site in a stable fashion.

AB - The herpes simplex virus (HSV) ICP47 protein inhibits the MHC class I antigen presentation pathway by inhibiting the transporter associated with antigen presentation (TAP) which translocates peptides across the endoplasmic reticulum membrane. At present, ICP47 is the only inhibitor of TAP. Here, we show that ICP47 produced in bacteria can block human, but not mouse, TAP, and that heat denaturation of ICP47 has no effect on its ability to block TAP. ICP47 inhibited peptide binding to TAP without affecting ATP binding, consistent, with previous observations that the peptide binding and ATP binding sites of TAP are distinct. ICP47 bound to TAP with a higher affinity (KD ~5 x 10-8 M) than did peptides, and ICP47 did not dissociate from TAP. ICP47 was not transported by TAP and remained sensitive to proteases added from the cytosolic surface of the membrane. Peptides acted as competitive inhibitors of ICP47 binding to TAP, and this inhibition required a 100- to 1000-fold molar excess of peptide. These results demonstrate that ICP47 binds to a site which includes the peptide binding domain of TAP and remains bound to this site in a stable fashion.

KW - Herpes simplex virus

KW - ICP47

KW - Peptide binding site

KW - TAP

UR - http://www.scopus.com/inward/record.url?scp=0030035445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030035445&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 3256

EP - 3266

JO - EMBO Journal

JF - EMBO Journal

SN - 0261-4189

IS - 13

ER -